1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow CKD-512: new trials by email Literature Review of CKD-512 trials Research Report on CKD-512
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors CKD-512, Pembrolizumab - Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 | Recruiting | Chong Kun Dang Pharmaceutical | 60 | 2025-10-16 | 2026-02-02 |
Chong Kun Dang Pharmaceutical (1)
South Korea (1)